| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.4 | 0.05 |